• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院老年人全因死亡率、肌肉减少症和肌肉减少性肥胖症之间的关系。

The relationship between all-cause mortality sarcopenia and sarcopenic obesity among hospitalized older people.

机构信息

Department of Geriatric Medicine, Ankara University School of Medicine, Ankara, Turkey.

Department of Geriatric Medicine, Ataturk's Training and Research Hospital, Ankara, Turkey.

出版信息

Aging Clin Exp Res. 2019 Nov;31(11):1563-1572. doi: 10.1007/s40520-019-01277-5. Epub 2019 Jul 26.

DOI:10.1007/s40520-019-01277-5
PMID:31350700
Abstract

BACKGROUND AND AIM

Sarcopenia and sarcopenic obesity (SO) are associated with adverse health outcomes in older people. Data on sarcopenia- and SO-related mortality are insufficient for hospitalized older people. The aim of this study was to evaluate the relationship between sarcopenia, SO and mortality among hospitalized older people.

METHODS

Two-centered prospective observational study was conducted among 350 hospitalized older people in geriatric units of two university hospitals. Sarcopenia was defined according to the European Working Group on Sarcopenia in Older People. Obesity was defined according to fat mass percentage. Medical history, cognitive status, nutritional status and functionality and laboratory tests were assessed. All-cause mortality rate was recorded at 2 years.

RESULTS

The prevalence of SO was 21.1%. The prevalence of sarcopenia was 11.4%. Both sarcopenia (log rank p < 0.001) and SO (log rank p < 0.001) were associated with all-cause mortality at 2 years. There was no difference between sarcopenia and SO for mortality. SO (HR 5.23, p < 0.001), sarcopenia (HR 9.26, p < 0.001), male gender (HR 2.25, p = 0.035), Lawton IADL (HR 0.77, p = 0.02), heart failure (HR 3.25, p = 0.02) and chronic obstructive lung disease (HR 5.16, p = 0.01) were independently related to all-cause mortality.

DISCUSSION AND CONCLUSIONS

Both sarcopenia and SO showed an independent relationship for 2-year all-cause mortality after hospital discharge. These results suggest that preventive and treatment options should be taken to decrease mortality associated with these conditions among hospitalized older people.

摘要

背景与目的

肌少症和肌少症性肥胖(SO)与老年人的不良健康结局相关。关于肌少症和 SO 相关死亡率的数据对于住院老年人来说还不够充分。本研究的目的是评估住院老年人中肌少症、SO 与死亡率之间的关系。

方法

对两所大学医院老年病房的 350 名住院老年人进行了为期 2 年的前瞻性观察性研究。肌少症根据欧洲老年人肌少症工作组的标准定义。肥胖根据体脂肪百分比定义。评估了病史、认知状态、营养状况和功能以及实验室检查。记录了全因死亡率。

结果

SO 的患病率为 21.1%。肌少症的患病率为 11.4%。肌少症(对数秩检验 p<0.001)和 SO(对数秩检验 p<0.001)均与 2 年时的全因死亡率相关。肌少症和 SO 对死亡率的影响没有差异。SO(HR 5.23,p<0.001)、肌少症(HR 9.26,p<0.001)、男性(HR 2.25,p=0.035)、Lawton IADL(HR 0.77,p=0.02)、心力衰竭(HR 3.25,p=0.02)和慢性阻塞性肺疾病(HR 5.16,p=0.01)与全因死亡率独立相关。

讨论与结论

肌少症和 SO 在出院后 2 年内均与全因死亡率独立相关。这些结果表明,应采取预防和治疗措施,以降低住院老年人与这些疾病相关的死亡率。

相似文献

1
The relationship between all-cause mortality sarcopenia and sarcopenic obesity among hospitalized older people.住院老年人全因死亡率、肌肉减少症和肌肉减少性肥胖症之间的关系。
Aging Clin Exp Res. 2019 Nov;31(11):1563-1572. doi: 10.1007/s40520-019-01277-5. Epub 2019 Jul 26.
2
Sarcopenia and mortality in older people living in a nursing home in Turkey.土耳其养老院老年人肌少症与死亡率的关系。
Geriatr Gerontol Int. 2017 Jul;17(7):1118-1124. doi: 10.1111/ggi.12840. Epub 2016 Jul 20.
3
Sarcopenia Is Related to Mortality in the Acutely Hospitalized Geriatric Patient.肌少症与急性住院老年患者的死亡率相关。
J Nutr Health Aging. 2019;23(2):128-137. doi: 10.1007/s12603-018-1134-1.
4
Impact of Sarcopenia on One-Year Mortality among Older Hospitalized Patients with Impaired Mobility.肌肉减少症对行动不便的老年住院患者一年死亡率的影响。
J Frailty Aging. 2018;7(1):40-46. doi: 10.14283/jfa.2017.35.
5
Malnutrition-sarcopenia syndrome and all-cause mortality in hospitalized older people.营养不良-肌少症综合征与住院老年患者的全因死亡率。
Clin Nutr. 2021 Nov;40(11):5475-5481. doi: 10.1016/j.clnu.2021.09.036. Epub 2021 Sep 27.
6
Association of sarcopenic obesity with the risk of all-cause mortality among adults over a broad range of different settings: a updated meta-analysis.在广泛的不同环境中,与成年人全因死亡率相关的肌少症性肥胖的关联:一项更新的荟萃分析。
BMC Geriatr. 2019 Jul 3;19(1):183. doi: 10.1186/s12877-019-1195-y.
7
Sarcopenia and sarcopenic obesity among men aged 80 years and older in Beijing: prevalence and its association with functional performance.北京80岁及以上男性的肌肉减少症和肌肉减少性肥胖:患病率及其与功能表现的关联
Geriatr Gerontol Int. 2014 Feb;14 Suppl 1:29-35. doi: 10.1111/ggi.12211.
8
Comparing EWGSOP2 and FNIH Sarcopenia Definitions: Agreement and 3-Year Survival Prognostic Value in Older Hospitalized Adults: The GLISTEN Study.比较 EWGSOP2 和 FNIH 肌少症定义:老年住院患者中的一致性和 3 年生存预后价值:GLISTEN 研究。
J Gerontol A Biol Sci Med Sci. 2020 Jun 18;75(7):1331-1337. doi: 10.1093/gerona/glz249.
9
Prevalence of Sarcopenia in Community-Dwelling Chilean Elders According to an Adapted Version of the European Working Group on Sarcopenia in Older People (EWGSOP) Criteria.根据老年人肌少症欧洲工作组(EWGSOP)标准的改编版本,智利社区居住老年人的肌少症患病率
J Frailty Aging. 2017;6(1):12-17. doi: 10.14283/jfa.2016.117.
10
Longitudinal associations between body composition, sarcopenic obesity and outcomes of frailty, disability, institutionalisation and mortality in community-dwelling older men: The Concord Health and Ageing in Men Project.社区居住的老年男性中,身体成分、肌少症性肥胖与虚弱、残疾、住院和死亡结局之间的纵向关联:康科德健康与老龄化男性研究。
Age Ageing. 2017 May 1;46(3):413-420. doi: 10.1093/ageing/afw214.

引用本文的文献

1
Association of possible sarcopenia and its components with all-cause mortality in a middle-aged and older population: a 9-year cohort study.中年及老年人群中潜在肌肉减少症及其组成部分与全因死亡率的关联:一项9年队列研究
Sci Rep. 2025 Aug 20;15(1):30481. doi: 10.1038/s41598-025-16034-0.
2
Prevalence of Sarcopenic Obesity in Elderly Population: A Meta-Analysis.老年人群中肌少性肥胖的患病率:一项荟萃分析。
Curr Aging Sci. 2025;18(2):147-162. doi: 10.2174/0118746098331277241101025928.
3
Sarcopenia, Obesity, or Both. What is the dominant Variable of the Associated Risks of Sarcopenic Obesity?
肌肉减少症、肥胖症,还是两者皆有?肌肉减少性肥胖相关风险的主要变量是什么?
Innov Aging. 2025 Mar 28;9(5):igaf021. doi: 10.1093/geroni/igaf021. eCollection 2025.
4
Association between possible sarcopenia, all-cause mortality, and adverse health outcomes in community-dwelling older adults in China.中国社区居住的老年人中可能的肌肉减少症与全因死亡率和不良健康结局的关系。
Sci Rep. 2024 Oct 29;14(1):25913. doi: 10.1038/s41598-024-77725-8.
5
Sarcopenia, sarcopenic obesity and the clinical outcome of the older inpatients with COVID-19 infection: a prospective observational study.肌肉减少症、肌少症性肥胖与 COVID-19 感染老年住院患者的临床结局:一项前瞻性观察研究。
BMC Geriatr. 2024 Jul 4;24(1):578. doi: 10.1186/s12877-024-05177-w.
6
Sarcopenic obesity in older adults: a clinical overview.老年人肌少症性肥胖:临床概述。
Nat Rev Endocrinol. 2024 May;20(5):261-277. doi: 10.1038/s41574-023-00943-z. Epub 2024 Feb 6.
7
Low lean mass with obesity in older adults with hypertension: prevalence and association with mortality rate.老年高血压患者中伴有肥胖的低瘦体重:患病率及其与死亡率的关联
BMC Geriatr. 2023 Oct 3;23(1):619. doi: 10.1186/s12877-023-04326-x.
8
Obesity phenotypes and cardiovascular risk: From pathophysiology to clinical management.肥胖表型与心血管风险:从病理生理学到临床管理。
Rev Endocr Metab Disord. 2023 Oct;24(5):901-919. doi: 10.1007/s11154-023-09813-5. Epub 2023 Jun 26.
9
The impact of sarcopenia and obesity on mortality of older adults: five years results.肌少症和肥胖对老年人死亡率的影响:五年结果
Ir J Med Sci. 2023 Oct;192(5):2209-2216. doi: 10.1007/s11845-023-03392-9. Epub 2023 May 19.
10
Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF.肌少症性肥胖与老年心力衰竭患者的身体功能受损和死亡率相关:来自 FRAGILE-HF 的观察。
BMC Geriatr. 2022 Jul 5;22(1):556. doi: 10.1186/s12877-022-03168-3.